Stuart Schnitt

Professor of Pathology @harvardmed, Chief of Breast Oncologic Pathology @DanaFarber, Senior Pathologist @BrighamWomens, Past President of @theUSCAP #BreastPath

[Christine Desmedt @ChristineDesme2]

Registration is now open for the annual invasive #lobular breast cancer symposium (https://t.co/kBqV5sOMt5) which will take place in Leuven, Belgium, this year on September 23-25! Register now as places are limited. @OncoAlert

[Ibex Medical Analytics @IbexMedAx]

A closer look at this #USCAP2024 study, evaluating Ibex’s #AI platform's performance in detecting microinvasive breast carcinoma & showing very high accuracy for AI in identifying these minute tumors: https://t.co/kbBsi8zXdH #breastcancer #pathology @BrighamWomens @SchnittStuart

[Michelle_Hirsch (Donovan) @MichelleDunno17]

The GOAT. 🔬🐐
@CFletcherMD

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer. Read the highlights 👉 https://t.co/4K9TttND8g

[Professor Richard Scolyer AO @ProfRAScolyer]

Day 2 post op & feeling much better. Still in #ICU at #RPAH/@SydneyLHD. Op seemed to have gone well. Just waiting on #neuropathology

[Professor Richard Scolyer AO @ProfRAScolyer]

Hi all! Feeling great in neuro ICU at #RPAH/@SydneyLHD. Thanks so much to my friend & colleague Dr Brindha Shivalingam & team for meeting with my wife Dr Katie Nicoll & @ProfGLongMIA yesterday & for operating on me today! Thanks to friends & colleagues around world & @MelanomaAus

[Chandrajit Raut @chandrajitraut]

Celebrating Chris Fletcher’s seminal contributions to #sarcoma care and our ⁦@DanaFarber⁩ ⁦@BrighamWomens⁩ sarcoma team with Beth Baldini, Andy Wagner, Suzanne George, George Demetri ⁦@DrSarcoma⁩ and ⁦@JLHornick⁩ ⁦⁦@BwhSurgOncology⁩

[TedPellaInc @TedPellaInc]

We are ready for you USCAP!!!

[Gary L. Thompson @garyleethompson]

Day 75/250 of my "tour" of @BCRFcure funded researchers... sometimes you get a 2-for-1... Dr. Schnitt and Dr. Tung, both at @DanaFarber, "are analyzing blood and tumor specimens collected from INFORM participants to better understand... 1/2 https://t.co/wPRFIMYPQi

[Dana-Farber’s Breast Oncology Center @DFCI_BreastOnc]

A New View of HER2 Expression | Join Drs. Tarantino, Schnitt and Reis-Filho on March 13 in Person or Online for this @PeerView Symposium ➡️Testing/Treatment Advice for #HER2Low #BreastCancer.
Register here: https://t.co/DAetZEPYva
@PTarantinoMD @SchnittStuart

[Stephanie Hart, MD @ihartpathology]

Patient presents with a 8 mm palpable breast mass. Diagnosis? What is the most common molecular finding for this entity? Answer and pearls in the comments! #PathTwitter #MedEd #breastpath #pathology

[Astrid Weins @AstridWeins]

I am deeply honored to announce that I have been appointed to succeed my mentor and teacher, Dr Helmut Rennke, as the next Chief of Renal Pathology @BWHPath @BWHkidney. I can only attempt to fill these massive shoes of a true giant and pioneer in our field.

[USCAP @TheUSCAP]

Announcing our 2023 Annual Meeting. See you in New Orleans!

https://t.co/CfrkXIOt7d

[Sara Tolaney @stolaney1]

Incredible lecture by @LANewmanMD who is dedicated to understanding and improving disparities in care and outcomes we see for our breast cancer patients; what an incredible way to honor the memory of Dr. Carolyn Kaelin!

@DFCI_BreastOnc #bcsm

[Olga Kantor MD, MS, FACS @OKantorMD]

An inspiring talk by @LANewmanMD at the 4th Annual Carolyn Kaelin Visiting Lecture @DFCI_BreastOnc @BrighamSurgery on triple negative breast cancer disparities and the role of ancestry in defining the path forward! @TariKingMD @gmdoherty @kaelin_lab

[Dr. E Mittendorf @EMittendorfMD]

@stolaney1 @DrHBurstein @AnnPartridgeMD @nlinmd @elmayermd - our work looking at racial differences in the immune response to breast cancer is a finalist for the BRIght futures prize. Can we count on your vote? (And spread the word😊)

[Tari King MD @TariKingMD]

Thanks for sharing your work and expertise with us @LANewman - a phenomenal way to resume our Carolyn Kaelin Visiting Professorship @BrighamSurgery @DFCI_BreastOnc

[Tari King MD @TariKingMD]

Looking forward to hosting Dr Lisa Newman @BrighamSurgery and @DFCI_BreastOnc for Carolyn Kaelin visiting Professorship.

[Grace L. Malvar, MD @DoktoraMalvar]

Dr. @SchnittStuart covering Updates on Lobular Carcinoma In Situ Classification and Management … WATCH OUT for invasive lobular carcinoma with aberrant e-Cadherin staining!

[Ibex Medical Analytics @IbexMedAx]

Are you in Basel for #ECP2022? join this talk by Drs. @SchnittStuart @JudithSandbank on practical implications of using #AI in breast #pathology, looking at real world cases reviewed with AI and findings from recent clinical studies. See you at our booth (#1)! @ESP_Pathology